Embecta Corp (EMBC) Live Share Price, Invest From India

Embecta Corp Stock Performance

as on December 18, 2025 at 2:29 am IST

Day's Low
Day's High
$11.78
Day's Price Range
$12.36
$11.79
0.08%
Downside
4.83%
Upside
52 Week's Low
52 Week's High
$9.2
52-Week Price Range
$21.23
$11.79
21.97%
Downside
80.07%
Upside

Embecta Corp share price movements today

Previous Close: $11.89
Open: $11.93
Volume: 713.0K
Day's Low - High: $11.78 - $12.36
52 Week Low - High: $9.2 - $21.23

Embecta Corp Historical Returns

1 Month Return: -16.91 %
3 Month Return: -21.05 %
1 Year Return: -40.01 %
3 Year Return: -64.63 %
5 Year Return: 0 %

Embecta Corp Stock Fundamentals & Key Indicators

Check Embecta Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$698.1M

EPS (TTM)

2.925

Dividend Yield

3.55%

Quarterly Earnings Growth YOY

0.83%

PE Ratio (TTM)

7.36

Industry PE ratio

-0.35549019607843135

PEG Ratio

EBITDA

356.0M

Revenue (TTM)

1.1B

Profit Margin

8.83%

Return On Equity TTM

0.00%

Embecta Corp Stock Valuation

Track how Embecta Corp P/E has moved over time to understand its valuation trends.

Embecta Corp in the last 5 years

Overview
Trends

Lowest (2.68x)

September 30, 2022

Industry (-0.36x)

December 17, 2025

Today (7.36x)

December 17, 2025

Highest (10.33x)

June 30, 2023

LowHigh

Today’s Price to Earnings Ratio: 7.36x

Embecta Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Embecta Corp with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Embecta Corp	SELL	$698.1M	NA	7.36	8.83%
Intuitive Surgical, Inc.	BUY	$200.6B	113.36%	74.11	28.58%
Resmed Inc.	BUY	$36.9B	15.73%	25.9	27.35%
West Pharmaceutical Services Inc	BUY	$19.6B	-2.61%	40.34	16.29%
Alcon Ag	BUY	$39.0B	22.74%	37.71	10.28%

See all

Stock Returns calculator for Embecta Corp Stock including INR - Dollar returns

The Embecta Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Embecta Corp investment value today

Current value as on today

₹65,891

Returns

₹34,109

(-34.11%)

Returns from Embecta Corp Stock

₹40,515 (-40.51%)

Dollar Returns*

₹6,406 (+6.41%)

Analyst Recommendation on Embecta Corp Stock

Based on 9 analysts

SELL

0.00%

Buy

44.44%

Hold

55.56%

Sell

Based on 9 analysts, 55.56% of analysts recommend a 'SELL' rating for Embecta Corp. Average target price of $16.67

Embecta Corp Share Price Target

Get share price movements and forecasts by analysts on Embecta Corp.

What analysts predicted

29.27%UPSIDE

Target Price

$16.67

Current Price

$11.79

Analyzed by

9 Analysts

Target

$16.67

Embecta Corp target price $16.67, a slight upside of 29.27% compared to current price of $11.79. According to 9 analysts rating.

Embecta Corp Stock’s Investor Sentiment and Interest

Search interest for Embecta Corp Stock has increased by 300% in the last 30 days, reflecting an upward trend in search activity.

Time period: November 18, 2025 to December 18, 2025

Change:300% versus previous 30 day period

Embecta Corp Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	286	281	277	287	272	286	261	259	295	264
Gross Profit	189	181	185	184	190	173	157	164	197	158
Operating Income	51	25	45	39	55	26	28	62	94	56
EBITDA	55	41	51	47	65	34	39	74	110	70
Interest Expense	27	27	27	27	27	29	27	26	26	26
Depreciation	8	9	9	10	11	5	11	11	11	5
Income Before Tax	20	5	14	9	27	-7	0	35	72	29
Income Tax Expense	4	-1	-5	-19	12	-21	0	12	26	2
Net Income	15	6	20	28	14	14	0	23	45	26
Net Profit Margin	5.31%	2.13%	7.25%	10.06%	5.39%	5.10%	-0.27%	9.07%	15.40%	10.00%

Embecta Corp Annual Profit & Loss

All numbers in Millions USD

	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Total Revenue	1,109	1,085	1,165	1,129	1,120	1,123	1,080
Gross Profit	786	762	800	774	749	735	676
Operating Income	502	486	492	309	221	166	242
EBITDA	538	524	530	400	245	192	294
Interest Expense	2	-	3	46	107	112	107
Depreciation	36	38	38	31	32	36	40
Income Before Tax	500	485	495	256	105	44	136
Income Tax Expense	68	58	80	33	35	-34	40
Net Income	432	427	414	223	70	78	95
Net Profit Margin	38.95%	39.39%	35.61%	19.80%	6.28%	6.97%	8.83%

Embecta Corp Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	6	20	28	14	14	-26	23	45	26
Operating Cash Flow	29	-13	24	-2	26	-5	31	81	84
Investing Cash Flow	-9	-2	-3	-9	-	-1	0	0	-7
Financing Cash Flow	-9	-13	-11	-11	-36	-45	-37	-62	-81
Change in Cash	9	-27	7	-24	-7	-57	-4	21	-5

Embecta Corp Annual Cash Flow

All numbers in Millions USD

	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Net Income	427	415	223	70	78	95
Operating Cash Flow	498	456	412	67	35	191
Investing Cash Flow	-41	-39	-24	-26	-15	-9
Financing Cash Flow	-456	-417	-48	-48	-73	-226
Change in Cash	-457	-417	330	-4	-52	-45

Global Institutional Holdings in Embecta Corp

Funds	Holdings
BlackRock Inc	15.18%
Vanguard Group Inc	9.35%
American Century Companies Inc	8.88%
River Road Asset Management, LLC	5.54%
Deerfield Management Co	4.7%

See all

Embecta Corp News & Key Events

Insights on Embecta Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Intuitive Surgical, Inc. has given 17.9% return, outperforming this stock by 82.5%
NO EFFECT
Against Peers
In the last 1 year, Resmed Inc. has given 7.4% return, outperforming this stock by 47.7%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 45.5M → 26.4M (in $), with an average decrease of 42.0% per quarter
NEGATIVE IMPACT
Price Dip
In the last 1 month, EMBC stock has moved down by -16.3%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 295.5M → 264.0M (in $), with an average decrease of 10.7% per quarter

About Embecta Corp

Embecta Corp. is a global diabetes care company. It is focused on providing solutions to people living with diabetes. It has a portfolio of products, including a range of pen needles, syringes and safety injection devices, which are complemented by its digital application designed to assist people with managing their diabetes. Its pen needles are sterile, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. In addition to pen needles, it sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It has clearance from the FDA for its proprietary disposable insulin delivery system, which is indicated for adults who require insulin to manage diabetes, including both type 1 (T1D) and type 2 (T2D).

Organisation	Embecta Corp
Headquarters	300 Kimball Drive, Parsippany, NJ, United States, 07054
Industry	Healthcare
CEO	Mr. Devdatt Kurdikar Ph.D.
E-voting on shares	Click here to vote

Key Management of Embecta Corp

Name	Title
Mr. Jeffrey Z. Mann	Senior VP, General Counsel, Head of Business Development & Corporate Secretary
Ms. Jean M. Casner	Senior VP & Chief Human Resources Officer
Mr. Shaun Curtis	Senior Vice President of Global Manufacturing & Supply Chain
Mr. Anthony M. Roth	VP, Chief Accounting Officer & Corporate Controller
Ms. Colleen Riley	Senior VP & Chief Technology Officer
Mr. Devdatt Kurdikar Ph.D.	President, CEO & Director
Mr. Jacob P. Elguicze	Senior VP & CFO
Mr. Pravesh Khandelwal	VP & Head of Investor Relations
Ms. Ginny Blocki	Senior Vice President of Global Marketing & Product Management
Mr. Tom Blount	Senior VP & President of North America

FAQs

What is Embecta Corp share price today?

Embecta Corp share price today is $11.79 as on December 18, 2025 at 2:29 am IST at the close of the market. Embecta Corp share today touched a day high of $12.36 and a low of $11.78.

What is the 52 week high and 52 week low for Embecta Corp share?

Embecta Corp share touched a 52 week high of $21.23 on January 6, 2025 and a 52 week low of $9.2 on June 27, 2025. Embecta Corp stock price today i.e. December 18, 2025 at 2:29 am IST is closed at $11.79,which is 44.47% down from its 52 week high and 28.15% up from its 52 week low.

What is Embecta Corp's market capitalisation today?

Embecta Corp market capitalisation is $0.00T as on December 18, 2025 at 2:29 am IST.

How to invest in Embecta Corp Stock (EMBC) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Embecta Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Embecta Corp Shares that will get you 0.1272 shares as per Embecta Corp share price of $11.79 per share as on December 18, 2025 at 2:29 am IST.

What is the minimum amount required to buy Embecta Corp Stock (EMBC) from India?

Indian investors can start investing in Embecta Corp (EMBC) shares with as little as ₹90.346 or $1 (as of December 18, 2025 at 7:38 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹903.46 in Embecta Corp stock (as per the Rupee-Dollar exchange rate as on December 18, 2025 at 7:38 am IST). Based on Embecta Corp share’s latest price of $11.79 as on December 18, 2025 at 2:29 am IST, you will get 0.8482 shares of Embecta Corp. Learn more about fractional shares .